Follow
Akihiko Nishimura
Akihiko Nishimura
Johns Hopkins, Department of Biostatistics
Verified email at jhu.edu - Homepage
Title
Cited by
Cited by
Year
Discontinuous Hamiltonian Monte Carlo for discrete parameters and discontinuous likelihoods
A Nishimura, D Dunson, J Lu
Biometrika 107 (2), 365–380, 2020
98*2020
Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection
A Koenecke, M Powell, R Xiong, Z Shen, N Fischer, S Huq, ...
Elife 10, e61700, 2021
48*2021
Prior-Preconditioned Conjugate Gradient Method for Accelerated Gibbs Sampling in “Large n, Large p” Bayesian Sparse Regression
A Nishimura, MA Suchard
Journal of the American Statistical Association 118 (544), 2468-2481, 2023
44*2023
Gradients Do Grow on Trees: A Linear-Time O(N)-Dimensional Gradient for Statistical Phylogenetics
X Ji, Z Zhang, A Holbrook, A Nishimura, G Baele, A Rambaut, P Lemey, ...
Molecular biology and evolution 37 (10), 3047-3060, 2020
352020
Large-scale inference of correlation among mixed-type biological traits with phylogenetic multivariate probit models
Z Zhang, A Nishimura, P Bastide, X Ji, RP Payne, P Goulder, P Lemey, ...
292021
Geometrically tempered hamiltonian monte carlo
A Nishimura, D Dunson
arXiv preprint arXiv:1604.00872, 2016
252016
Bayesian constraint relaxation
LL Duan, AL Young, A Nishimura, DB Dunson
Biometrika 107 (1), 191-204, 2020
242020
Recycling intermediate steps to improve Hamiltonian Monte Carlo
A Nishimura, D Dunson
Bayesian Analysis, 2020
162020
Shrinkage-based random local clocks with scalable inference
AA Fisher, X Ji, A Nishimura, G Baele, P Lemey, MA Suchard
Molecular biology and evolution 40 (11), msad242, 2023
152023
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM
R Khera, LS Dhingra, A Aminorroaya, K Li, JJ Zhou, F Arshad, C Blacketer, ...
BMJ medicine 2 (1), 2023
142023
Shrinkage with shrunken shoulders: Gibbs sampling shrinkage model posteriors with guaranteed convergence rates
A Nishimura, MA Suchard
Bayesian analysis 18 (2), 367, 2023
10*2023
Accelerating Bayesian inference of dependency between mixed-type biological traits
Z Zhang, A Nishimura, NS Trovão, JL Cherry, AJ Holbrook, X Ji, P Lemey, ...
PLoS computational biology 19 (8), e1011419, 2023
7*2023
International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients
A Nishimura, J Xie, K Kostka, T Duarte-Salles, S Fernández Bertolín, ...
Frontiers in pharmacology 13, 945592, 2022
7*2022
Zigzag path connects two Monte Carlo samplers: Hamiltonian counterpart to a piecewise deterministic Markov process
A Nishimura, Z Zhang, MA Suchard
Journal of the American Statistical Association, 1-23, 2024
6*2024
Ten rules for conducting retrospective pharmacoepidemiological analyses: example COVID-19 study
M Powell, A Koenecke, JB Byrd, A Nishimura, MF Konig, R Xiong, ...
Frontiers in Pharmacology, 1799, 2021
6*2021
Variable length trajectory compressible hybrid Monte Carlo
A Nishimura, D Dunson
arXiv preprint arXiv:1604.00889, 2016
42016
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and …
CX Cai, A Nishimura, MG Bowring, E Westlund, D Tran, JH Ng, P Nagy, ...
Ophthalmology Retina, 2024
32024
Bayesian safety surveillance with adaptive bias correction
F Bu, MJ Schuemie, A Nishimura, LH Smith, K Kostka, T Falconer, ...
Statistics in Medicine 43 (2), 395-418, 2024
32024
Misuse of statistical method results in highly biased interpretation of forensic evidence in
M Rosenblum, ET Chin, EL Ogburn, A Nishimura, D Westreich, A Datta, ...
Law, probability and risk 23 (1), mgad010, 2024
32024
Clusters of post-acute COVID-19 symptoms: a latent class analysis across 9 databases and 7 countries
D Prieto-Alhambra, KL Güell, M Català, D Dedman, T Duarte-Salles, ...
22024
The system can't perform the operation now. Try again later.
Articles 1–20